At Boreal, we are committed to improving cancer patient care through development of research tools and diagnostic tests based on monitoring of circulating tumor DNA in plasma.
Boreal’s OnTarget™ platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. The OnTarget™ assay is available as a research-use service to reveal tumor mutations that are undetectable with other methods and may help guide selection of therapy, improve clinical trial efficiency, and accelerate drug development programs.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2386 East Mall, Vancouver,bc V6t 1z3,canada
- Phone
- 604-822-8268
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- borealgenomics.com
- HQ
- Vancouver, BC
Boreal Genomics Questions
Boreal Genomics's helpline number is 604-822-8268
Boreal Genomics's website is borealgenomics.com
Boreal Genomics's LinkedIn profile is https://ca.linkedin.com/company/boreal-genomics
Boreal Genomics has
2 employees.
View email and phone details for 2
employees at Boreal Genomics.
Boreal Genomics's industry is
Biotechnology Research
Boreal Genomics's top competitors are
Adaptive Biotechnologies Corp.,
Genome British Columbia,
Aquaeye / Vodasafe Inc,
Xenon Pharmaceuticals Inc.,
Virogin Biotech,
Bold Therapeutics Inc.,
Natera,
Fusion Genomics Corporation,
Signalchem Biotech Inc.,
Aqua Mergers + Acquisitions.
Boreal Genomics's support email address is info@borealgenomics.com
Boreal Genomics's categories are Biotechnology Research
Boreal Genomics's founding year is 2007
